Mild to Moderate Alzheimer's Disease
10 clinical trials · Condition
◉ Watch Mild to Moderate Alzheimer's Disease
| Record | Firm | Date |
|---|---|---|
| Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease (NCT03867253) | Oryzon Genomics S.A. | 2019-05-16 |
| Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease (NCT03625622) | AriBio Co., Ltd. | 2019-04-01 |
| A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. (NCT03507790) | Cognition Therapeutics | 2018-10-10 |
| Study of LM11A-31-BHS in Mild-moderate AD Patients (NCT03069014) | PharmatrophiX Inc. | 2017-02-15 |
| NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. (NCT02703636) | Novartis Pharmaceuticals | 2016-05-09 |
| The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study (NCT02256306) | Stanford University | 2014-09-01 |
| 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (NCT01039701) | AstraZeneca | 2009-12-01 |
Track Mild to Moderate Alzheimer's Disease automatically
Every clearance here is in the API, with alerts when new ones post.